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Abstract
Background: d-chiroinositol (DCI) is a inositolphosphoglycan (IPG) involved in several cellular functions that control
the glucose metabolism. DCI functions as second messenger in the insulin signaling pathway and it is considered
an insulin sensitizer since deficiency in tissue availability of DCI were shown to cause insulin resistance (IR).
Polycystic ovary syndrome (PCOS) is a pathological condition that is often accompanied with insulin resistance. DCI
can positively affects several aspect of PCOS etiology decreasing the total and free testosterone, lowering blood
pressure, improving the glucose metabolism and increasing the ovulation frequency. The purpose of this study was
to evaluate the effects of DCI and insulin combined with gonadotrophins namely follicle-stimulating hormone (FSH)
and luteinizing hormone (LH) on key steroidogenic enzymes genes regulation, cytochrome P450 family 19 subfamily
A member 1 (CYP19A1) and cytochrome P450 side-chain cleavage (P450scc) in primary cultures of human granulosa
cells (hGCs). We also investigated whether DCI, being an insulin-sensitizer would be able to counteract the
expected stimulator activity of insulin on human granulosa cells (hGCs).
Methods: The study was conducted on primary cultures of hGCs. Gene expression was evaluated by RT-qPCR
method. Statistical analysis was performed applying student t-test, as appropriate (P < 0.05) set for statistical
significance.
Results: DCI is able to reduce the gene expression of CYP19A1, P450scc and insulin-like growth factor 1 receptor
(IGF-1R) in dose–response manner. The presence of DCI impaired the increased expression of steroidogenic enzyme
genes generated by the insulin treatment in gonadotrophin-stimulated hGCs.
Conclusions: Insulin acts as co-gonadotrophin increasing the expression of steroidogenic enzymes genes in
gonadotrophin-stimulated granulosa cells. DCI is an insulin-sensitizer that counteracts this action by reducing the
expression of the genes CYP19A1, P450scc and IGF-1R. The ability of DCI to modulate in vitro ovarian activity of
insulin could in part explain its beneficial effect when used as treatment for conditions associated to insulin
resistance.
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Background
The cis-1, 2, 4-trans-3, 5, 6-Cyclohexanehexol, also
known as d-chiroinositol (DCI), is a six-carbon polyalco-
hol which belongs to the family collectively referred to
as inositol which is a part of the B vitamin family. At
cellular level inositols are incorporated into cell mem-
branes as phosphatidyl-myo-inositol, the precursor of
inositol triphosphate which acts as second messenger
and regulates the activities of different hormones such
as follicle-stimulating hormone (FSH) and insulin [1].
Epimerase enzymes convert inositols to up to nine ste-
reoisomers including myo-inositol (MI) and DCI while
the majority of the other stereoisomers generated fail to
show an evident biological activity [2]. MI and DCI are
both endogenous biosynthesized and introduced from
dietary sources such as buckwheat [3], Cucurbita ficifolia
[4] and soy lecithin [5].
DCI is considered as an insulin sensitizer since ino-
sitolphosphoglycan (IPG) mediators are involved in
several cellular functions that control the glucose me-
tabolism [6, 7].
Moreover, impaired metabolism of IPG mediators as
well as a deficiency in tissue availability of inositol were
shown to cause insulin resistance [8, 9].
Since DCI is synthetized by an epimerase that converts
in vivo MI to DCI, several studies observed that a de-
creased DCI in urine as well as tissues of human sub-
jects and animals with type 2 diabetes was accompanied
by an increase in MI content [10, 11].
Additional investigations demonstrated that the altered
inositol excretion patterns in human and monkey urine
were specifically related to the underlying insulin resist-
ance (IR), rather than to the diabetes type. To explain
the altered pattern of urine inositol excretion observed
under IR, a defect in the epimerization process was
hypothesized.
When IR occurs, the conversion rate is affected, result-
ing in a decreased level of DCI in cells.
In 2003 the European Society for Human Reproduction
and Embryology (ESHRE) and the American Society for
Reproductive Medicine (ASRM) established that patients
can be affected by polycystic ovary syndrome (PCOS)
when at least two conditions as anovulation or hyperan-
drogenism or increased ovarian volume are verified at the
same time. However, PCOS patients are often affected by
IR and it was hypothesized that a DCI deficiency, which
functions as second messanger in the insulin signaling
pathway [12], can be related to IR [13].
It has been demonstrated that DCI can positively af-
fects several aspect of PCOS etiology [8, 14]. In these
studies DCI was able to decrease the total and free tes-
tosterone, to lower blood pressure acting as insulin
sensitizer by improving the glucose metabolism, and fi-
nally to increase the ovulation frequency [8, 14, 15].
Insulin has been reported to be able to interact with
steroidogenic enzymes in granulosa and luteinic cells of
the ovaries [16–20]. Specifically insulin seems to potenti-
ate the FSH and luteinizing hormone (LH) induction of
cytochrome P450 family 19 subfamily A member 1
(CYP19A1) aromatase and this effect has been shown to
be so evident that insulin is considered by many as a
co-gonadotrophin [17–19, 21]. The co-treatment, in
vitro, with insulin-sensitizers, such as metformin or
thiazelinediones, counteracts the potent action of insu-
lin on human granulosa cells (hGCs) enzymes hence
showing the relevance of insulin activity for ovarian
cells physiology [16–21].
The objective of this study was to expand on this argu-
ment, hence investigating the possible effect of insulin
on the ovarian response to both the two gonadotrophins
FSH and LH. We specifically investigated the modifica-
tions of the gene expression of two key genes in ste-
roidogenesis, the aromatase CYP19A1 and cytochrome
P450 side-chain cleavage (P450scc). We also evaluated
whether DCI, being an insulin-sensitizer would be able




Patients selected (n = 8) for this study were heathy, had
regular menstrual cycles and had a mean age of 34 (±8).
Patients underwent in vitro fertilization (IVF) because of
male infertility. Clinical exclusion criteria adopted were:
previous ovarian surgery, positivity for Chlamydia anti-
body testing (CAT), presence of ovarian cysts, history of
pelvic inflammatory disease (PID), any known metabolic
or endocrinological disease.
Patients underwent IVF cycles according the
gonadotrophin-releasing hormone (GnRH) antagonist
protocol. Patients received recombinant human FSH
(rhFSH, Gonal F®, Merck Serono, Italy or Puregon®,
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MSD Organon, Italy) at a dose of at least 150 inter-
national units (IU) a day subcutaneously from day 2 or 3
of a spontaneous menstrual cycle. The GnRH antagonist,
Ganirelix (Orgalutran, Schering-Plough) or Cetrorelix
(Cetrotide, Merck Serono, Italy), was next administered
daily by subcutaneous injection (0.25 mg/d) from the
day of the stimulation cycle when the first follicle
reached 14 mm in size to the day of human chorionic
gonadotrophin (hCG) administration. When follicles
reached ≥18 mm, 10000 IU of hCG were administrated
intramuscularly and 34–36 h later follicles were aspi-
rated under patient sedation. hGCs were isolated from
ovarian follicles of women undergoing oocyte retrieval
for IVF protocol. Study approval was obtained from the
local ethics committee and informed, written consent
was obtained from each patient.
Granulosa-lutein cell isolation and primary cell culture
hGCs were purified by centrifugation through a disconti-
nuos Percoll (Amersham, Sweden) gradient as indicated in
[22], and cultured individually in 24 wells plate (50 x 103
cells/well) in McCoy 5A medium (Carlo Erba, Italy) sup-
plemented with 5 % foetal bovine serum (FBS) South
America (EU Approved, Carlo Erba, Italy), 2mM L-
Glutamine, 1 % Penicillin/Streptomicin and 1 % Ampho-
tericin B (Sigma Aldrich, St. Louis, MO, USA). Primary
hGCs culture were mantained at 37 °C under a controlled
atmosphere of 5 % CO2 for 6 days to avoid side effect due
to IVF hormones treatment, and subjected to medium
changes with fresh culture medium daily.
Treatments
hGCs primary cultures were initially incubated in star-
vation medium (McCoy 5A medium supplemented with
0.1 % FBS South America without antibiotics) for 12 h
to synchronize cells before the treatments. hGCs were
then incubated for 24 h with 0,1 IU/ml of long-acting
insulin (Levemir®, Novo Nordisk, Denmark). hGCs
insulin-treated where additionally incubated with 20
nM or 10 nM DCI (LJ Pharma, Italy) alone or in com-
bination with either 5 μM rhFSH, (Gonal-F®, Merck
Serono, Italy) or 5 μM of recombinant human LH
(rhLH, Luveris®, Merck Serono, Italy) for further 24 h.
DCI and gonadotrophins were dissolved into starvation
medium. Experiments were repeated in triplicate. Nega-
tive controls using corresponding amount of vehicle
control for insulin treatment and for each of gonado-
trophin used were performed. Comparison between
negative controls performed and untreated cells showed
no differences in terms of cells vitality, toxic effects or
impaired gene expression caused directly by the vehicle
in which substances were dissolved.
Trypan blue exclusion test of cell viability
To assess the viability of gonadotrophin treated hGCs
primary cultures, the Trypan Blue (Sigma Aldrich, St.
Louis, MO, USA) exclusion test was performed. hGCs
corresponding to each treatment and controls were sub-
merged in 0.4 % Trypan Blue in 1X Dulbecco’s phos-
phate buffered saline (DPBS, Sigma Aldrich, St. Louis,
MO, USA) solution directly in the wells then immedi-
ately counted (n = 200) under inverted microscope Primo-
Vert (Carl Zeiss Microscopy GmbH, Germany).
Percentage of viable cells were calculated and expressed
as ratio between blue-stained dead cells and not colored
viable cells.
Evaluation of gene expression by RT-qPCR
Collected hGCs after each treatment were immediately
processed for total RNA extraction using commercial
product Tri-Reagent® (Sigma Aldrich, St Louis, MO,
USA) following the manufacturer protocol. After an op-
tional DNase I (Promega, Madison, WI, USA) digestion
of 30 min at 37 °C the extracted RNA was evaluated and
quantified by spectrophotometry using Nanodrop ND-
1000 (Thermo Fisher Scientific, Waltham, MA, USA)
and 2 μg of RNA of each sample was reverse transcribed
to cDNA using iScript™ cDNA Synthesis Kit (Bio-Rad,
Hercules, CA, USA) according to datasheet. 2 μL of
cDNA of each sample was tested in triplicate in RT-
qPCR using SsoAdvanced Universal SYBR® Green Super-
mix (Bio-Rad, Hercules, CA, USA) following the condi-
tions suggested by the manufacturer’s protocol. Primers
used (listed in Table 1) in RT-qPCR reaction were de-
signed, where possible, across the intron to avoid gDNA
contaminants amplification. All primers used has similar
melting temperature so the general thermal profile of
the reaction is for all the genes tested 30 s at 95 °C to
initially activate the enzyme followed by 40 cycles of 95 °C
for 5 s and 60 °C for 20 s for each cycle. Results were nor-
malized by using the reference gene Ribosomal protein S7
(RpS7) gene. The specificity of each assay was validated by
dissociation curve analysis and amplicons were separated
by gel electrophoresis and imaged. Assay performance
was validated by evaluating amplification efficiencies by
means of calibration curves, and ensuring that the plot of
log input amount versus DCq (also known as DCT) has a
slope. Each reaction was repeated in triplicate. Negative
control reactions omitted templates.
Statistical analysis
Statistical analysis was performed applying student t-test,
as appropriate (P < 0.05) set for statistical significance. The
relative expression of each gene has been evaluated
using the 2-ΔΔCt method [23] and was calculated as the
relative ratio in comparison to the first control sample,
set arbitrarily to 1.
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Results
To investigate a possible role of DCI as modulator of
gene expression, hGCs primary culture were treated for
24 h with increasing concentrations of DCI dissolved
into starvation medium. In order to assess the cell viabil-
ity at the end of the DCI treatment the Trypan Blue
exclusion test was performed while the β3 integrin gene
activation, expressed as ratio normalized by RpS7 refer-
ence gene on RT-qPCR assay, was studied as positive
control (Fig. 1).
At all concentrations of DCI tested the calculated pre-
centage of viable hGCs was higher than 95 % without
any remarkable difference among treatments and in
comparison to the untreated hGCs control (data not
shown). As Fig. 1 shows, DCI is able to directly decrease
the β3 integrin gene expression of hGCs in a dose–re-
sponse manner. DCI-treated primary cultures of hGCs
that failed to show decrease of β3 integrin gene expres-
sion were excluded from further analysis.
d-chiroinositol affects the steroidogenic enzymes gene
expression
The effect of 24 h incubation with increasing dosages of
DCI on steroidogenic enzymes gene activation in pri-
mary cultures of hGCs was studied by RT-qPCR and
expressed as ratio normalyzed by RpS7 reference gene.
Figure 2 shows the dose–response curve generated by
different concentrations of DCI on CYP19A1 (Fig. 2a)
and P450scc (Fig. 2b) gene expression.
Fig. 1 Effect of 24 h incubation with increasing dosage of DCI,
range 0 nM - 20 nM, on β3 integrin gene expression normalized by
the reference RpS7 gene in primary culture of hCGs in vitro by RT-
qPCR. Significant differences versus the respective controls were
marked by * p < 0.05, Student’s t-test
Fig. 2 Evaluation of dose–response effect of 24 h incubation with
DCI on a aromatase CYP19A1 and b P450scc genes expression in
primary culture of hGCs by RT-qPCR. Significant differences versus
the respective controls were marked by * p < 0.05, Student’s t-test
Table 1 Primers list used in RT-qPCR
Gene Protein name Sequence 5′- 3′ Amplicon lenght (bp) NCBI Ref. sequence
RpS7 Ribosomal protein S7 F: AATCTTTGTTCCCGTTCCTCA 135 NM_001011.3
R: CGAGTTGGCTTAGGCAGAA
β3 integrin β3 integrin F: GACAAGGGCTCTGGAGACAG 233 NM_000212.2
R: ACTGGTGAGCTTTCGCATCT
IGF1R Insulin-like growth factor 1 receptor F: CGTGGGAGGGTTGGTGATTA 161 NM_000875.3
R: TGGCCACTCTGGTTTCAGGT
CYP19A1 Aromatase F: CCCTTCTGCGTCGTGTCAT 86 NM_000103.3
R: GATTTTAACCACGATAGCACTTTCG
P450scc (CYP11A1) Cholesterol side-chain cleavage enzyme F: ACCAAGAACTTTTTGCCCCT 127 NM_000781.2
R: ATGTCCCCCGAGTAATTTCC
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DCI has tendency to decrease the expression of both
genes analyzed at the lowest concentrations tested and
this effect is particularly significative with higher DCI
dosages which were choosen and employed for following
experiments.
The insulin up-regulation of the steroidogenic enzyme
genes response to gonadotrophins is balanced by
d-chiroinositol treatment
Primary cultures of hGCs were treated with gonadotro-
phins alone and in combination with 0,1 IU/ml insulin
or 20 nM DCI or both. Steroidogenic enzymes gene ex-
pression was calculated by RT-qPCR reactions and
expressed as ratio normalyzed by RpS7 refrence gene.
The addition of 5 ng/ml rhFSH (Fig. 3) or 5 ng/ml rhLH
(Fig. 4) was associated to a significant activation of gene
expression of both CYP19A1 and P450scc. Expectantly,
the co-incubation of gonadotrophins with 0,1 IU/ml of
insulin resulted significantly more effective in inducing
the two genes when compared to rhFSH alone (Fig. 3a, b)
and rhLH alone (Fig. 4a). When added in the cultural
system, the samples incubated with 20 nM DCI show no
significative differences if compared with the effect gener-
ated by gonadotrophin alone treatment (Figs. 3 and 4).
Meanwhile, the positive contribution of insulin to the ste-
roidogenic genes induction generated by gonadotrophins
is impaired by DCI co-incubation.
Finally both concentrations of DCI tested (10 nM or
20 nM) revealed that DCI is able to directly reduce insu-
lin-like growth factor 1 receptor (IGF-1R) gene expres-
sion while the co-incubation of DCI and 0,1 U of insulin
in the culture system is not producing significatively dif-
ferences between treated and untreated hGCs controls
(Fig. 5).
Discussion
In the present study we demonstrated that insulin and
DCI are able to affect directly the gene expression of two
pivotal steroidogenic enzymes gene namely CYP19A1 and
P450scc. Moreover, DCI may modulate the stimulatory
effects on steroidogenic genes mediated by both gonado-
trophins and insulin.
The efficiency of the cultural system in which DCI
treatments affected the genes regulation in hGCs pri-
mary cultures was evaluated trough the analysis of the
expression of β3 integrin gene. Integrins are membrane
receptors involved in cells-extracellular matrices adhe-
sion and in the signal transduction that are differentially
Fig. 3 Effect of 24 h incubation with 5 ng/ml rhFSH on a CYP19A1 and b P450scc gene expression alone, and in combination with 0,1 U insulin
or 20 nM DCI or both in primary culture of hGCs cells in vitro. Different letters indicate different significances at p < 0.05, Student’s t test
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and stage-specifically expressed on hGCs [24]. It was
shown that integrins are able to regulate different hGCs
functions [25] as well as the corpus luteum formation
[26, 27]. For these reasons, it was hypothesized a pos-
sible role of integrins during folliculogenesis [28–30].
Moreover, in a different study conducted to evaluate a
possible anti-metastasis effects of D-pinitol, a 3-methoxy
DCI analogue, in human prostate cancer cells, it was
demonstrated that noncytotoxic concentrations of D-
pinitol reduced mRNA and cell surface expression of the
β3 integrin fraction on prostate cancer cells [31]. Based
on the percentage of viable cells after the Trypan Blue
exclusion assay, increasing concentrations of DCI were
able to reduce the β3 integrin gene expression in all the
hGCs primary cultures employed in this study.
In addition, our analyses show that DCI acts directly
on steroidogenic enzymes gene regulation of hGCs
reducing mRNA expression of both CYP19A1 and
P450scc genes in dose–response manner. P450scc en-
zymes catalyze many reactions involved in synthesis of
cholesterol and steroids and togheter with the aromatase
CYP19A1 are required to regulate estradiol and proges-
terone production within the ovary [32].
However, because the mature granulosa-lutein cells used
for this in vitro study may not reflect the in vivo condition,
the experiments were also conducted in presence of go-
nadotrophins and insulin. Both the gonadotrophins (alone
or in combination) induce expression of CYP19A1 and
P450scc genes [33, 34] although gonadotrophin-related
profile of gene expression exists [35, 36]. It is also widely
demonstrated that insulin plays a role in the ovarian func-
tions by enhancing the gonadotrophin effects as showed
in theca cells [37, 38] and in granulosa cells [39, 40]. In
our experimental model, incubation with rhFSH or rhLH
were able to induce CYP19A1 and P450scc gene expres-
sion according with previously published data [36]. More-
over, our data confirmed that insulin could influence
steroidogenesis by increasing the stimulatory effects of LH
and FSH, as showed in our study, by increasing the ex-
pression of steroidogenic enzyme genes. Interestingly the
positive effect of insulin on gonadotrophin-stimulated
hGCs was counter-acted by the presence of DCI. How-
ever, the hGCs cultured in presence of DCI were still re-
sponsiveness to gonadotrophins as the CYP19A1 and
P450scc were significatively induced if compared to the
untreated hGCs control.
Since it was also reported that DCI plays a role as sec-
ond messengers in the classical phosphorylation signaling
pathways activated by insulin triggering the activation of
Mg2+-dependent protein phosphatases (MPPs) family
which control the glucose metabolism [5], we investigate
the effects of co-treatment with DCI and insulin in hGCs.
Fig. 4 Effect of 24 h incubation with 5 ng/ml rhLH on a CYP19A1
and b P450scc gene expression alone, and in combination with 0,1
U insulin or 20 nM DCI or both in primary culture of hGCs in
vitro. Different letters indicate different significances at
p <0.05, Student’s test
Fig. 5 Dose–response effect of 24 h of incubation with 10 nM or 20
nM DCI alone or in combination with 0,1 U insulin on IGF1R gene
expression in primary culture of hGCs in vitro by RT-qPCR. Significant
differences versus untreated controls were marked by * p < 0.05,
Student’s t-test
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Notoriously, insulin exerts its function not only by
binding insulin receptors present on the surface of target
cells but also functioning as ligand for IGF-1R [41]. The
typical ligand for IGF-1R is the hormone insulin-like
growth factor (IGF) that is considered to have co-
gonadotrophin effects.
In the last years one of the most studied of the in vivo
pathology related to infertility was the PCOS. The PCOS
is characterized by elevated levels of insulin and IGF-1R
[42] and it has been hypothesized that this could influ-
ence the pathogenesis of the syndrome and the alter-
ations of sexual steroids commonly frequent in patients
affected by PCOS. IGF-1R is present on the cellular
membrane of hGCs [43] and it has been demonstrated
that different insulin sensitizer drugs such metformin
are able to modulate gene expression [20, 44].
In the present study, we showed not only that DCI is
able to balance the additional stimulatory effect on ste-
roidogenic enzyme gene of gonadotrophins stimulated
hGCs, but also we firstly demonstrated that incubation of
hGCs with increasing dosage of DCI resulted in a de-
creased IGF-1R expression in a dose-dependency manner.
Conclusions
In conclusion, in the present study we could confirm the
effect of insulin as co-gonadotrophin on granulosa cells
from the ovaries and we could demonstrate that DCI, an
insulin-sensitizers counteract this action. This was
evident when the expression of several genes was inves-
tigated, such as aromatase CYP19A1, P450scc and IGF-1
receptor. The ability of DCI to modulate in vitro ovarian
activity of insulin could at least in part explain its benefi-
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